Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A de Jong

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Disability and Rehabilitation|January 17, 2003
On autonomy and participation in rehabilitationM Cardol, B A De Jong, C D Ward
Clinical and Experimental Immunology|September 1, 1992
A recombinant topoisomerase I ELISA: screening for IgG, IgM and IgA anti-topo I autoantibodies in human seraR Verheijen, B A de Jong, W J van Venrooij
Clinical Rehabilitation|August 4, 1998
Intra-articular triamcinolone acetonide injection in patients with capsulitis of the shoulder: a comparative study of two dose regimensB A de Jong, R Dahmen, J A Hogeweg, et al.
American Journal of Physical Medicine & Rehabilitation|January 1, 1997
The painful hemiplegic shoulder: effects of intra-articular triamcinolone acetonideJ H Dekker, R C Wagenaar, G J Lankhorst, et al.
Molecular Biology Reports|February 1, 1992
Molecular cloning of a major CENP-B epitope and its use for the detection of anticentromere autoantibodiesR Verheijen, B A de Jong, E H Oberyé, et al.
BMC Neurology|May 13, 2020
Neuroprotective effects of exercise in people with progressive multiple sclerosis (Exercise PRO-MS): study protocol of a phase II trialA S Gravesteijn, H Beckerman, B A de Jong, et al.
Annals of the Rheumatic Diseases|December 1, 1995
Shoulder disorders in general practice: incidence, patient characteristics, and managementD A van der Windt, B W Koes, B A de Jong, et al.
Genes and Immunity|February 22, 2002
Polymorphisms in or near tumour necrosis factor (TNF)-gene do not determine levels of endotoxin-induced TNF productionB A de Jong, R G J Westendorp, A M Bakker, et al.
Therapeutic Drug Monitoring|December 11, 2012
Removal of valproic acid by plasmapheresis in a patient treated for multiple sclerosisD E T Bastiaans, I W M van Uden, R A Ruiterkamp, et al.
Clinical Rehabilitation|August 17, 2000
The effects of knee-ankle-foot orthoses in the treatment of Duchenne muscular dystrophy: review of the literatureJ P Bakker, I J de Groot, H Beckerman, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Disability and Rehabilitation|January 17, 2003
On autonomy and participation in rehabilitationM Cardol, B A De Jong, C D Ward
Clinical and Experimental Immunology|September 1, 1992
A recombinant topoisomerase I ELISA: screening for IgG, IgM and IgA anti-topo I autoantibodies in human seraR Verheijen, B A de Jong, W J van Venrooij
Clinical Rehabilitation|August 4, 1998
Intra-articular triamcinolone acetonide injection in patients with capsulitis of the shoulder: a comparative study of two dose regimensB A de Jong, R Dahmen, J A Hogeweg, et al.
American Journal of Physical Medicine & Rehabilitation|January 1, 1997
The painful hemiplegic shoulder: effects of intra-articular triamcinolone acetonideJ H Dekker, R C Wagenaar, G J Lankhorst, et al.
Molecular Biology Reports|February 1, 1992
Molecular cloning of a major CENP-B epitope and its use for the detection of anticentromere autoantibodiesR Verheijen, B A de Jong, E H Oberyé, et al.
BMC Neurology|May 13, 2020
Neuroprotective effects of exercise in people with progressive multiple sclerosis (Exercise PRO-MS): study protocol of a phase II trialA S Gravesteijn, H Beckerman, B A de Jong, et al.
Annals of the Rheumatic Diseases|December 1, 1995
Shoulder disorders in general practice: incidence, patient characteristics, and managementD A van der Windt, B W Koes, B A de Jong, et al.
Genes and Immunity|February 22, 2002
Polymorphisms in or near tumour necrosis factor (TNF)-gene do not determine levels of endotoxin-induced TNF productionB A de Jong, R G J Westendorp, A M Bakker, et al.
Therapeutic Drug Monitoring|December 11, 2012
Removal of valproic acid by plasmapheresis in a patient treated for multiple sclerosisD E T Bastiaans, I W M van Uden, R A Ruiterkamp, et al.
Clinical Rehabilitation|August 17, 2000
The effects of knee-ankle-foot orthoses in the treatment of Duchenne muscular dystrophy: review of the literatureJ P Bakker, I J de Groot, H Beckerman, et al.
Pageof 4